Thornberry Nancy bought DNLI
June 3, 2026 · Form 4 insider transaction
Thornberry Nancy bought 6,408 shares of Denali Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,408
Price
$0.00
Total value
N/A
InsiderThornberry Nancy
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 3, 2026
Filing dateJune 5, 2026
Shares owned after31,125
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.; Includes 6,408 unvested RSUs.